2019
DOI: 10.1016/j.jcms.2019.07.022
|View full text |Cite
|
Sign up to set email alerts
|

Targeting inhibitors of apoptosis in oral squamous cell carcinoma in vitro

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 51 publications
0
5
0
Order By: Relevance
“…However, most cancer cell lines tested were resistant to the treatment of Smac mimetic [113,134,135]. To overcome the resistance of these cancers to anti-tumorigenic drugs, combination therapies with other anticancer drugs are being explored [136][137][138]. Some studies have reported accelerated disease growth after treatment with the monovalent Smac mimetic LCL161 in a lymphoma mouse model, and a cytokine release syndrome that showed an increased TNFα levels in patients treated with LCL161 [139,140].…”
Section: Targeting Xiap For Cancer Therapy; Developing Smac and Arts mentioning
confidence: 99%
“…However, most cancer cell lines tested were resistant to the treatment of Smac mimetic [113,134,135]. To overcome the resistance of these cancers to anti-tumorigenic drugs, combination therapies with other anticancer drugs are being explored [136][137][138]. Some studies have reported accelerated disease growth after treatment with the monovalent Smac mimetic LCL161 in a lymphoma mouse model, and a cytokine release syndrome that showed an increased TNFα levels in patients treated with LCL161 [139,140].…”
Section: Targeting Xiap For Cancer Therapy; Developing Smac and Arts mentioning
confidence: 99%
“…Like all carcinomas, OSCC consists of transformed epithelial cells that display a strong resistance to programmed cell death (apoptosis) [79]. In this regard, it must be highlighted that the intracellular signaling pathways stimulated by F. nucleatum and P. gingivalis hamper apoptosis promoters such as p53 or Bad [40,44] in oral keratinocytes (Table 1).…”
Section: Effects Of P Gingivalis and F Nucleatum Leading To The Onset...mentioning
confidence: 99%
“…Unfortunately, most cancer cell lines are resistant to SMs [ 383 , 392 , 393 ]. Therefore, combinations with other anti-cancer drugs are being explored in an effort to overcome resistance [ 394 , 395 , 396 ]. Historically, SMs were developed to target XIAP, but until recently, no potent XIAP-only inhibitors were available [ 34 , 356 ].…”
Section: Targeting the Ups For Apoptosis-induced Cancer Therapymentioning
confidence: 99%